In MLL-AF6 positive AML cells, BHLHE41 has been reported to interact with MLL-AF6 and activate several leukemogenic genes, such as FOXD4L1, CDK6, and ZNF521 [17]. This evidence concerns the gene KMT2A and acute myeloid leukemia.